Literature DB >> 23090280

Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up?

Brian Bello1, Marco Zoccali, Roberto Gullo, Marco E Allaix, Fernando A Herbella, Arunas Gasparaitis, Marco G Patti.   

Abstract

BACKGROUND: Many surgeons feel comfortable performing antireflux surgery (ARS) on the basis of symptomatic evaluation, endoscopy, and barium esophagography. While esophageal manometry is often obtained to assess esophageal peristalsis, pH monitoring is rarely considered necessary to confirm the diagnosis of gastroesophageal reflux disease (GERD). AIMS: The aim of this study was to analyze the sensitivity and specificity of symptoms, endoscopy, barium esophagography, and manometry as compared to pH monitoring in the preoperative evaluation of patients for ARS. PATIENTS AND METHODS: One hundred and thirty-eight patients were referred for ARS with a diagnosis of GERD based on symptoms, endoscopy, and/or barium esophagography. Barium esophagography, esophageal manometry, and ambulatory 24-h pH monitoring were performed preoperatively in every patient.
RESULTS: Four patients were found to have achalasia and were excluded from the analysis. Based on the presence or absence of gastroesophageal reflux on pH monitoring, the remaining 134 patients were divided into two groups: GERD+ (n = 78, 58 %) and GERD- (n = 56, 42 %). The groups were compared with respect to the incidence of symptoms, presence of reflux and hiatal hernia on esophagogram, endoscopic findings, and esophageal motility. There was no difference in the incidence of symptoms between the two groups. Within the GERD+ group, 37 patients (47 %) had reflux at the esophagogram and 41 (53 %) had no reflux. Among the GERD- patients, 17 (30 %) had reflux and 39 (70 %) had no reflux. A hiatal hernia was present in 40 and 32 % of patients, respectively. Esophagitis was found at endoscopy in 16 % of GERD+ patients and in 20 % of GERD- patients. Esophageal manometry showed no difference in the pressure of the lower esophageal sphincter or quality of peristalsis between the two groups.
CONCLUSIONS: The results of this study showed that (a) symptoms were unreliable in diagnosing GERD, (b) the presence of reflux or hiatal hernia on esophagogram did not correlate with reflux on pH monitoring, (c) esophagitis on endoscopy had low sensitivity and specificity, and (d) manometry was mostly useful for positioning the pH probe and rule out achalasia. Ambulatory 24-h pH monitoring should be routinely performed in the preoperative work-up of patients suspected of having GERD in order to avoid unnecessary ARS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090280     DOI: 10.1007/s11605-012-2057-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis.

Authors:  Y Amano; N Ishimura; K Furuta; K Okita; M Masaharu; T Azumi; T Ose; K Koshino; S Ishihara; K Adachi; Y Kinoshita
Journal:  Endoscopy       Date:  2006-10       Impact factor: 10.093

3.  Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.

Authors:  I Mainie; R Tutuian; A Agrawal; D Adams; D O Castell
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

4.  Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms.

Authors:  M G Patti; M Arcerito; A Tamburini; U Diener; C V Feo; B Safadi; P Fisichella; L W Way
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

5.  The preoperative evaluation of patients considered for laparoscopic antireflux surgery.

Authors:  J P Waring; J G Hunter; M Oddsdottir; J Wo; E Katz
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

6.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis.

Authors:  P Bytzer; T Havelund; J M Hansen
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

7.  Clinical, radiological, and manometric profile in 145 patients with untreated achalasia.

Authors:  Piero M Fisichella; Dan Raz; Francesco Palazzo; Ian Niponmick; Marco G Patti
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

8.  [Relationship between gastroesophageal reflux symptoms and 24 h esophageal pH measurement in patients with normal or minimally abnormal upper endoscopies].

Authors:  Attila Csendes; Guillermo Rencoret; Marcelo Beltran; Gladys Smok; Ana Henríquez
Journal:  Rev Med Chil       Date:  2004-01       Impact factor: 0.553

Review 9.  Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management.

Authors:  J E Richter
Journal:  Gastroenterol Clin North Am       Date:  1996-03       Impact factor: 3.806

10.  Gastroesophageal reflux disease: correlation of esophageal pH testing and radiographic findings.

Authors:  M Y Chen; D J Ott; J W Sinclair; W C Wu; D W Gelfand
Journal:  Radiology       Date:  1992-11       Impact factor: 11.105

View more
  19 in total

1.  Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Authors:  Leonardo M Del Grande; Fernando A M Herbella; Amilcar M Bigatao; Henrique Abrao; Jose R Jardim; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2015-09-24       Impact factor: 3.452

Review 2.  GERD procedures: when and what?

Authors:  P Marco Fisichella; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2014-07-01       Impact factor: 3.452

3.  Role of the Barium Esophagram in Antireflux Surgery.

Authors:  Mark E Baker
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

Review 4.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  Is resection of an esophageal epiphrenic diverticulum always necessary in the setting of achalasia?

Authors:  Marco E Allaix; Bernardo A Borraez Segura; Fernando A Herbella; Piero M Fisichella; Marco G Patti
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

6.  Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.

Authors:  Marco E Allaix; Piero M Fisichella; Imre Noth; Fernando A Herbella; Bernardo Borraez Segura; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

7.  Cardiac autonomic dysfunction in patients with gastroesophageal reflux disease.

Authors:  Branislav Milovanovic; Branka Filipovic; Slavica Mutavdzin; Marija Zdravkovic; Tatjana Gligorijevic; Jovana Paunovic; Marina Arsic
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 8.  Evaluation of gastroesophageal reflux disease.

Authors:  Piero Marco Fisichella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

Review 9.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

10.  Importance of esophageal manometry and pH monitoring for the evaluation of otorhinolaryngologic (ENT) manifestations of GERD. A multicenter study.

Authors:  Fernando A M Herbella; Ciro Andolfi; Yalini Vigneswaran; Marco G Patti; Bruno R Pinna
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.